BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33144446)

  • 1. Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.
    Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
    In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
    Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
    BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison of vaginal vault ovoid brachytherapy versus intensity-modulated radiation therapy plans in postoperative patients of cervical carcinoma following whole pelvic radiotherapy.
    Khosla D; Patel FD; Oinam AS; Tomar P; Sharma SC
    J Cancer Res Ther; 2014; 10(1):153-8. PubMed ID: 24762503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
    Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
    Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filling the gap in central shielding: three-dimensional analysis of the EQD2 dose in radiotherapy for cervical cancer with the central shielding technique.
    Tamaki T; Ohno T; Noda SE; Kato S; Nakano T
    J Radiat Res; 2015 Sep; 56(5):804-10. PubMed ID: 26062811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    Jiang Y; Wang J; Jiang P; Wang X; Zhang L; Zhang Y
    BMC Cancer; 2023 May; 23(1):481. PubMed ID: 37245053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
    Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
    J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
    Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
    Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer.
    Ye X; Ye P; Zheng Y; Xia W
    J BUON; 2021; 26(4):1298-1305. PubMed ID: 34564984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
    Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different treatment plans on EQD
    Gul OV; Inan G; Basaran H
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):28. PubMed ID: 34604928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
    Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
    J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.